Search research articles
Contact Us
Filters
Showing results (521-530 of 721) with videos related to
Page
of 73
Sort By:
Plos One
|
December 2, 2021
Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results
Nils Martin Bruckmann, Julian Kirchner, Janna Morawitz, et al.
Cancers
|
July 2, 2021
Multiparametric Integrated <sup>18</sup>F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
Lale Umutlu, Julian Kirchner, Nils Martin Bruckmann, et al.
EJNMMI Research
|
October 31, 2018
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
Katharina Lückerath, Liu Wei, Wolfgang P Fendler, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
January 1, 2014
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma
Zhoulei Li, Ken Herrmann, Sabine Pirsig, et al.
Clinical Nuclear Medicine
|
March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
Christina Bluemel, Markus Krebs, Bülent Polat, et al.
Theranostics
|
May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach
Rudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2021
<sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
Nader Hirmas, Catherine Leyh, Miriam Sraieb, et al.
Leukemia
|
October 14, 2022
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial
Robert Seifert, David Kersting, Christoph Rischpler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2025
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [<sup>177</sup>Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Loïc Djaileb, Andrea Farolfi, Isabel Rauscher, et al.
Der Radiologe
|
April 2, 2020
[Hybrid imaging of the abdomen and pelvis. German version]
Krista Elise Suarez-Weiss, Alexander Herold, Debra Gervais, et al.
Page
of 73
Search research articles
Search
Showing results (521-530 of 721) with videos related to
Sort By:
Page
of 73
Plos One
|
December 2, 2021
Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results
Nils Martin Bruckmann, Julian Kirchner, Janna Morawitz, et al.
Cancers
|
July 2, 2021
Multiparametric Integrated <sup>18</sup>F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
Lale Umutlu, Julian Kirchner, Nils Martin Bruckmann, et al.
EJNMMI Research
|
October 31, 2018
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
Katharina Lückerath, Liu Wei, Wolfgang P Fendler, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
January 1, 2014
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma
Zhoulei Li, Ken Herrmann, Sabine Pirsig, et al.
Clinical Nuclear Medicine
|
March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
Christina Bluemel, Markus Krebs, Bülent Polat, et al.
Theranostics
|
May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach
Rudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2021
<sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
Nader Hirmas, Catherine Leyh, Miriam Sraieb, et al.
Leukemia
|
October 14, 2022
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial
Robert Seifert, David Kersting, Christoph Rischpler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2025
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [<sup>177</sup>Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Loïc Djaileb, Andrea Farolfi, Isabel Rauscher, et al.
Der Radiologe
|
April 2, 2020
[Hybrid imaging of the abdomen and pelvis. German version]
Krista Elise Suarez-Weiss, Alexander Herold, Debra Gervais, et al.
Page
of 73